News

Stay up to date on our latest stories.

Filters

Supporting communities during the holiday season in Portugal

Story, Responsibility
Supporting communities during the holiday season in Portugal

Supporting food security across our communities in the US

Story, Responsibility
Supporting food security across our communities in the US

Supporting students with disabilities in Egypt

Story, Responsibility
Supporting students with disabilities in Egypt

Hikma announces CEO change and Board appointment

Press Release, Corporate
Hikma announces CEO change and Board appointment

Inspiring women of Hikma - Meet Cristina Cagnazzi, Finance Director, Hikma Italy

Story, Leadership
Inspiring women of Hikma - Meet Cristina Cagnazzi, Finance Director, Hikma Italy

European Injectables growth: a Q&A with Nassim Rahmani, Associate VP, Commercial Europe & Canada

Insight, Corporate
European Injectables growth: a Q&A with Nassim Rahmani, Associate VP, Commercial Europe & Canada

Hikma launches TYZAVAN™ (vancomycin injection, USP) in the US

Press Release, Product
Hikma launches TYZAVAN™ (vancomycin injection, USP) in the US

Inspiring women of Hikma - Meet Susana Pereira Sr. Director Quality Systems & Validation – EU & MENA Injectables

Story, Leadership
Inspiring women of Hikma - Meet Susana Pereira Sr. Director Quality Systems & Validation – EU & MENA Injectables

Hikma celebrates 20 years on the London Stock Exchange

Story, Corporate
Hikma celebrates 20 years on the London Stock Exchange

Strategic priorities in Hikma Pharmaceuticals R&D: Q&A with Hafrun Fridriksdottir, President Rx and R&D

Insight, Corporate
Strategic priorities in Hikma Pharmaceuticals R&D: Q&A with Hafrun Fridriksdottir, President Rx and R&D

Hikma signs an exclusive agreement with DGI Group to bring Claritag® to the MENA region

Press Release, Business Development
Hikma signs an exclusive agreement with DGI Group to bring Claritag® to the MENA region

Hikma confirms 2025 guidance and updates medium-term growth outlook

Press Release, Financial Results
Hikma confirms 2025 guidance and updates medium-term growth outlook

Hikma Pharmaceuticals announces the launch of STARJEMZA™ (ustekinumab-hmny) Injection, a biosimilar referencing STELARA®...

Press Release, Product
Hikma Pharmaceuticals announces the launch of STARJEMZA™ (ustekinumab-hmny) Injection, a biosimilar referencing STELARA®...

Hikma R&D. Innovating Formulation Development. Meet Razan Alsawwaf

Story, Life at Hikma
Hikma R&D. Innovating Formulation Development. Meet Razan Alsawwaf

Supporting Breast Cancer Awareness Month at Hikma

Story, Responsibility
Supporting Breast Cancer Awareness Month at Hikma